Jüri Reimand platform talk at ASHG 2025

Jüri Reimand gave a platform presentation at the annual meeting of the American Society of Human Genetics in Boston, on the lab’s work uncovering mutational processes and driver mutations delineated by topoisomerase II binding in cancer genomes.